Positive results from clinical trials of an immune therapy in dogs with bone cancer have been used to fast-track the development of the drug to treat children with the same cancer. It highlights how ...

FRAMINGHAM, MA / ACCESS Newswire / May 14, 2025 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immuno-oncology ...

Avammune Therapeutics secured $12 million in Series A funding to advance its small molecule immunotherapies targeting cancer ...

Chemotherapy uses anti cancer (cytotoxic) drugs to destroy cancer cells. It works well for some types of bone cancers such as Ewing sarcoma and osteosarcoma. You usually have chemotherapy before and ...

“The primary objective of this study is to explore safety and tolerability in patients with relapsed/refractory osteosarcoma or Ewing sarcoma receiving XBIO-015 in combination with relapsed ...

FRAMINGHAM, MA / ACCESS Newswire / March 26, 2025 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immuno ...

To confirm the promising results of the CABONE study, a future phase 3 trial with cabozantinib will be considered, even if it will be a challenge for rare diseases such as Ewing sarcoma and ...

Long-term survival rates for bone cancers - such as osteosarcoma and Ewing sarcoma - haven't changed in over 15 years, new research by the University of Nottingham shows. Fewer than seven in 10 ...

Pooled proportions of symptoms and signs were calculated. Results 16 studies (1452 patients; 492 osteosarcoma and 932 Ewing’s sarcoma) were included in the analysis. The most prevalent symptoms were ...

But it can be a clue because your ALP and LDH levels may be very high if you have osteosarcoma or Ewing sarcoma. Staging is the process your doctor will use to figure out if your cancer has spread ...

In this study, bioinformatics methods were used to analyze and explain the genetic correlation between osteosarcoma and Ewing’s sarcoma, and to screen the co-morbid marker molecules of the two, in ...